The KEAP1-NRF2 System in Cancer

Frontiers in Oncology
Keiko Taguchi, Masayuki Yamamoto

Abstract

Cancer cells first adapt to the microenvironment and then propagate. Mutations in tumor suppressor genes or oncogenes are frequently found in cancer cells. Comprehensive genomic analyses have identified somatic mutations and other alterations in the KEAP1 or NRF2 genes and in well-known tumor suppressor genes or oncogenes, such as TP53, CDKN2A, PTEN, and PIK3CA, in various types of cancer. Aberrant NRF2 activation in cancer cells occurs through somatic mutations in the KEAP1 or NRF2 gene as well as through other mechanisms that disrupt the binding of KEAP1 to NRF2. Unregulated NRF2 confers on cancer cells high-level resistance to anticancer drugs and reactive oxygen species (ROS) and directs cancer cells toward metabolic reprogramming. Therefore, NRF2 has been studied as a therapeutic target molecule in cancer. Two strategies have been used to target NRF2 via therapeutic drugs: inhibition of NRF2 and induction of NRF2. NRF2 inhibitors may be effective against NRF2-addicted cancer cells in which NRF2 is aberrantly activated. These inhibitors have not yet been established as NRF2-targeted anticancer drugs for the treatment of human cancers. Diagnosis of NRF2 activation could facilitate the use of NRF2 inhibitors for the treatment...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangG H Posner
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R S FrilingV Daniel
Jul 27, 1981·Biochimica Et Biophysica Acta·W WillinghamI H Hall
Jan 1, 1995·Journal of Cellular Biochemistry. Supplement·T W Kensler, K J Helzlsouer
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Albena T Dinkova-KostovaPaul Talalay
Feb 7, 2003·The Biochemical Journal·Elisabeth BalogunRoberto Motterlini
Jul 19, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mark PinesArnon Nagler
Feb 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Moon-Il KangMasayuki Yamamoto
Dec 2, 2004·Molecular and Cellular Biology·Donna D ZhangMark Hannink
Nov 15, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Thomas W KenslerPaul Talalay
Dec 16, 2005·Molecular and Cellular Biology·Akira KobayashiMasayuki Yamamoto
Mar 2, 2006·Molecular Cell·Balasundaram PadmanabhanMasayuki Yamamoto
Oct 6, 2006·PLoS Medicine·Anju SinghShyam Biswal
Oct 2, 2007·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Yoriko WataiMasayuki Yamamoto
Jan 16, 2008·Developmental Cell·Gerasimos P Sykiotis, Dirk Bohmann
Feb 7, 2008·Chemical Research in Toxicology·Girish RachakondaMichael L Freeman
Jun 17, 2008·Biochemical and Biophysical Research Communications·Rui WangDeshan Zhou
Jan 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Dongmei RenDonna D Zhang
Jan 22, 2011·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Keiko TaguchiMasayuki Yamamoto
Jun 4, 2011·Breast Cancer Research and Treatment·Muhua YangQun Zhou
Jul 22, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kai Connie WuCurtis D Klaassen
Sep 20, 2011·The Journal of Biological Chemistry·Gabriel EadesQun Zhou
Oct 5, 2011·Neoplasia : an International Journal for Oncology Research·Tatsuhiro ShibataMasayuki Yamamoto

❮ Previous
Next ❯

Citations

Jan 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carole Nicco, Frédéric Batteux
Jan 13, 2018·Antioxidants & Redox Signaling·Luksana ChaiswingDaret K St Clair
Mar 30, 2018·Journal of Bioenergetics and Biomembranes·John A HanoverMichelle R Bond
May 3, 2018·Physiological Reviews·Masayuki YamamotoHozumi Motohashi
Dec 8, 2017·Biomolecules & Therapeutics·Byung-Jin JungSang-Min Jeon
Apr 28, 2018·Current Opinion in Nephrology and Hypertension·Sarah A StrausserTomokazu Souma
Apr 11, 2019·Metallomics : Integrated Biometal Science·Lauren D PalmerEric P Skaar
Mar 7, 2018·Pharmacological Reviews·Antonio CuadradoHarald H H W Schmidt
Jul 31, 2019·International Journal of Molecular Sciences·Yi Xiao, David Meierhofer
Sep 5, 2019·Antioxidants·Ana PaunkovGerasimos P Sykiotis
Sep 29, 2019·Clinical and Experimental Pharmacology & Physiology·Pritha BoseShakti P Pattanayak
Oct 30, 2019·Pediatric Hematology and Oncology·Dilara Fatma Akın-BalıTeoman Kankılıc
Jan 25, 2020·Nanomaterials·Mathilde Biola-ClierMarie Carriere
Mar 4, 2020·International Journal of Molecular Sciences·Ricardo U Macías-RodríguezFrancisco Javier Cubero
Feb 29, 2020·Antioxidants·Emiliano PanieriLuciano Saso
Apr 21, 2020·Free Radical Research·Takujiro Homma, Junichi Fujii
Apr 30, 2020·Carcinogenesis·Feng HeMichael Karin
Oct 23, 2018·Biomedical Reports·Raúl Barrera-Rodríguez
May 30, 2020·International Journal of Oncology·Daniel L PouliquenCatherine Guette
Sep 13, 2019·Cell Communication and Signaling : CCS·Jiang-Jiang QinWei-Dong Zhang
May 13, 2018·Annals of the New York Academy of Sciences·Shaohua MaXiaoxin Luke Chen
Jun 6, 2018·Frontiers in Oncology·Nikos Koundouros, George Poulogiannis
Apr 13, 2018·Oxidative Medicine and Cellular Longevity·F P FabrizioL A Muscarella
Apr 20, 2018·Oxidative Medicine and Cellular Longevity·Yan-Yang WangHong Zhe
Jun 20, 2018·The Journal of Cell Biology·Ankita Bansal, M Celeste Simon
Jul 26, 2018·Frontiers of Medicine·Kohei MiyazonoMasato Morikawa
Aug 22, 2018·Molecular and Cellular Biology·E W CloerM B Major
Feb 14, 2019·International Journal of Molecular Sciences·Sandhya ChipurupalliNirmal Robinson
Mar 21, 2019·Frontiers in Pharmacology·Lei LiuSylvain Doré
Jun 20, 2019·Biochemistry. Biokhimii︠a︡·O V KosmachevskayaA F Topunov
Nov 14, 2019·Cancers·Alina-Andreea ZimtaIoana Berindan-Neagoe
Sep 18, 2020·International Journal of Molecular Sciences·Chia-Hung YenHui-Hua Hsiao
Jan 2, 2019·International Journal of Molecular Sciences·Bastian CzogallaFabian Trillsch
May 7, 2020·Biomolecules·Piergiorgio La RosaFiorella Piemonte
Aug 14, 2020·Autoimmune Diseases·Mohammad Javad TavassolifarMaryam Izad

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
ChIP-Seq
xenograft

Software Mentioned

COSMIC

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.